<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>and target virus &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/and-target-virus/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 14 Dec 2025 06:27:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>and target virus &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Modified Coxsackie B1 Vaccine Triggers Strong Immune Response</title>
		<link>https://bioengineer.org/modified-coxsackie-b1-vaccine-triggers-strong-immune-response/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 14 Dec 2025 06:27:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[and target virus]]></category>
		<category><![CDATA[Based on the content focusing on the novel vaccine design]]></category>
		<category><![CDATA[here are 5 suitable tags: **Coxsackie B1 vaccine]]></category>
		<category><![CDATA[immune response]]></category>
		<category><![CDATA[Immunoreactive region exclusion]]></category>
		<category><![CDATA[neutralizing antibodies]]></category>
		<category><![CDATA[Vaccine development** **Explanation:** 1. **Coxsackie B1 vaccine:** Directly names the specific virus and the subject (the vaccine). 2. **Virus-like particles (VLP):** Highlights]]></category>
		<category><![CDATA[Virus-like particles (VLP)]]></category>
		<guid isPermaLink="false">https://bioengineer.org/modified-coxsackie-b1-vaccine-triggers-strong-immune-response/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have made significant strides in the development of a novel vaccine targeting the Coxsackie B1 virus, a member of the enterovirus family known for its potential to cause various diseases, including myocarditis and meningitis. This new vaccine is particularly noteworthy as it has been engineered to exclude a highly conserved [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307600</post-id>	</item>
	</channel>
</rss>
